tirzepatide molecular structure Antidiabetic drug molecula | Stock Image Tirzepatide, a New Era of

As of this writing, the FDA has not yet formally published the updated Category 2 list following Secretary Kennedy's February 27, 2026 announcement

This also means they cant participate in clinical trials that take place at hospitals or research institutions, and even people who can get to those places will likely end up with PEM as an inevitable by-product, Copeland said

If the defense system cannot effectively remove these toxic products, it can result in an irreversible point of no return in the progression of ferroptosis

Its a direct investment in a healthier, more vibrant, and potentially less expensive future

As clinical familiarity with incretin-based drugs improves, treatment adoption is poised to expand beyond endocrinology practices into primary care settings